Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CVS Corporation Reports Second Quarter Diluted EPS of 49 Cents, Up 14%.


Business Editors

WOONSOCKET Woonsocket (wnsŏk`ĭt, wn–), city (1990 pop. 43,877), Providence co., N R.I. , R.I.--(BUSINESS WIRE)--July 30, 2003

CVS (1) (Concurrent Versions System) A version control system for Unix that was initially developed as a series of shell scripts in the mid-1980s. CVS maintains the changes between one source code version and another and stores all the changes in one file.  Corporation (NYSE NYSE

See: New York Stock Exchange
: CVS) today announced sales and earnings for the second quarter ended June June: see month.  28, 2003.

Net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
 for the second quarter ended June 28, 2003 increased 7.6% to a record $6.44 billion, up from $5.99 billion during the second quarter of 2002. Same store sales Same Store Sales

A statistic used in retail industry analysis. It compares sales of stores that have been open for a year or more.

Notes:
This statistic allows investors to determine what portion of new sales has come from sales growth and what portion from the opening of
 (sales from stores open more than one year) for the quarter rose 5.5%, while pharmacy pharmacy, art of compounding and dispensing drugs and medication. The term is also applied to an establishment used for such purposes. Until modern times medication was prepared and dispensed by the physician himself. In the 18th cent.  same store sales rose 7.5% and front-end front-end
adj.
1. Of or relating to the initial phase of a project: a front-end investment.

2. Of or relating to the forward parts of a vehicle: a front-end alignment.
 same store sales increased 1.4%. The Company estimates the Easter Easter [A.S. Eastre, name of a spring goddess], chief Christian feast, commemorating the resurrection of Jesus after his crucifixion. In the West, Easter is celebrated on the Sunday following the full moon next after the vernal equinox (see calendar); thus, it  shift had a positive impact of approximately ap·prox·i·mate  
adj.
1. Almost exact or correct: the approximate time of the accident.

2.
 200 basis points on front-end same store sales for the thirteen-week period. Pharmacy same store sales were negatively impacted by approximately 200 basis points for the quarter by recent generic drug generic drug, a drug sold or prescribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than under a brand or trade name.  introductions, which are being substituted for higher priced brand name drugs. Total pharmacy sales represented 68.9% of total company sales for the quarter. Third party prescription sales were 92.6% of pharmacy sales for the quarter.

Net earnings for the second quarter increased 13.3% to $199.8 million or $0.49 per diluted di·lute  
tr.v. di·lut·ed, di·lut·ing, di·lutes
1. To make thinner or less concentrated by adding a liquid such as water.

2. To lessen the force, strength, purity, or brilliance of, especially by admixture.
 share, compared with net earnings of $176.4 million or $0.43 per diluted share in the second quarter of 2002. The Company's second quarter results were driven by the growth in sales, and a significant improvement in gross margin, which primarily reflects the increased usage of generic Generic

Describes the characteristics and/or experience of the total universe of a coupon of MBS sector type; that is, in contrast to a specific pool or collateral group, as in a specific CMO issue.
 pharmaceuticals and improvements in inventory losses.

"This was an outstanding quarter that is clearly reflected in the sales growth and 14% increase in CVS' diluted earnings per share diluted earnings per share

An earnings measure calculated by dividing net income less preferred stock dividends for a period by the average number of shares of common stock that would be outstanding if all convertible securities were converted into shares of
. Pharmacy sales momentum continued to pick up throughout the quarter, while gross margin increased solidly," stated Tom Ryan
This article refers to the United States gamer. For other persons named Tom Ryan, see the disambiguation page..


Tom Ryan (born August 3 1986), who plays under the pseudonym Ogre 2, is a professional gamer from Pickerington, Ohio, USA.
, Chairman, President, and Chief Executive Officer of CVS Corporation. "We also made excellent progress on the rollout of our Pharmacy Service Initiative as well as our AIM inventory initiative for pharmacy in-stock positions. Both are helping us gain market share," Mr. Ryan Ryan may refer to: Places
  • Division of Ryan, an electoral district in the Australian House of Representatives, in Queensland
  • Ryan, Iowa
  • Ryan, Oklahoma
  • Ryan Township, Pennsylvania
  • Ryan, New South Wales
Film and television
 continued. "Our new store expansion program is right on track and we expect that it will give us a solid platform for long-term Long-term

Three or more years. In the context of accounting, more than 1 year.


long-term

1. Of or relating to a gain or loss in the value of a security that has been held over a specific length of time. Compare short-term.
 growth."

For the second quarter, CVS opened 26 new stores, closed 12 and relocated re·lo·cate  
v. re·lo·cat·ed, re·lo·cat·ing, re·lo·cates

v.tr.
To move to or establish in a new place: relocated the business.

v.intr.
 24 others. As of June 28, 2003, CVS operated 4,113 retail and specialty pharmacy stores in 32 states and the District of Columbia District of Columbia, federal district (2000 pop. 572,059, a 5.7% decrease in population since the 1990 census), 69 sq mi (179 sq km), on the east bank of the Potomac River, coextensive with the city of Washington, D.C. (the capital of the United States). .

The Company will be holding a conference call today for the investment community at 8:30am (ET) to discuss the quarterly results. The call will be simulcast Simulcast is a portmanteau of "simultaneous broadcast", and refers to programs or events broadcast across more than one medium, or more than one service on the same medium, at the same time.  on the Company's Web site for all interested parties. To access the webcast, visit the Company's Web site at http://investor.CVS.com on the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 page to hear the call live, or to listen to an archive (1) A file that contains one or more compressed files. Most archive formats are also capable of storing folders in order to reconstruct the file/folder relationship when decompressed. See archive formats.  of the call, which will be available for a one-week period following the call.

Celebrating 40 years of dynamic growth in the retail pharmacy industry, CVS is committed to being the easiest pharmacy retailer for customers to use. CVS has created innovative approaches to serve the healthcare needs of all customers through its over 4,100 CVS/pharmacy CVS/pharmacy (also CVS) is a pharmacy and convenience store chain in the United States. CVS is also the largest pharmacy chain in the United States, based on the number of stores. (R) stores, its online pharmacy This article or section may deal primarily with the U.S. and may not present a worldwide view. ; CVS.com(R) and its pharmacy benefit management A Pharmacy Benefit Manager (PBM) is a third party administrator of prescription drug programs. They are primarily responsible for processing and paying prescription drug claims.  and specialty pharmacy subsidiary, PharmaCare Management Services.

This press release contains certain forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 that are subject to risks and uncertainties that could cause actual results to differ materially. For these statements, the Company claims the protection of the safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 for forward-looking statements contained in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. The Company strongly recommends that you become familiar with the specific risks and uncertainties outlined under the caption "Cautionary Statement Concerning Forward-Looking Statements" in its Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the fiscal year ended December December: see month.  28, 2002 and in its Quarterly Report on Form 10-Q Form 10-Q

See 10-Q.
 for the quarter ended March 29, 2003.

                            CVS CORPORATION
            Consolidated Condensed Statements of Operations
                              (Unaudited)

                               13 Weeks Ended       26 Weeks Ended
                              June 28,  June 29,   June 28,   June 29,
In millions, except per share    2003      2002       2003       2002
 amounts
                             --------- --------- ---------- ----------
Net sales                    $6,444.9  $5,989.5  $12,757.7  $11,960.2
Cost of goods sold, buying
 and warehousing costs        4,811.1   4,508.4    9,518.4    8,985.4
                             --------- --------- ---------- ----------
 Gross margin                 1,633.8   1,481.1    3,239.3    2,974.8
Selling, general and
 administrative expenses      1,211.4   1,104.0    2,403.0    2,226.2
Depreciation and amortization    85.4      78.8      168.0      153.8
                             --------- --------- ---------- ----------
 Total operating expenses     1,296.8   1,182.8    2,571.0    2,380.0
                             --------- --------- ---------- ----------
Operating profit                337.0     298.3      668.3      594.8
Interest expense, net            12.7      13.8       25.3       26.9
                             --------- --------- ---------- ----------
Earnings before income tax
 provision                      324.3     284.5      643.0      567.9
Income tax provision            124.5     108.1      246.9      215.8
                             --------- --------- ---------- ----------
Net earnings                    199.8     176.4      396.1      352.1
Preference dividends, net of
 income tax benefit               3.7       3.7        7.3        7.4
                             --------- --------- ---------- ----------
Net earnings available to
 common shareholders           $196.1    $172.7     $388.8     $344.7
                             --------- --------- ---------- ----------
Basic earnings per common
 share:
  Net earnings                  $0.50     $0.44      $0.99      $0.88
                             --------- --------- ---------- ----------
 Weighted average basic
  common shares outstanding     394.0     392.0      393.7      391.8
                             --------- --------- ---------- ----------

Diluted earnings per common
 share:(1)
  Net earnings                  $0.49     $0.43      $0.97      $0.86
                             --------- --------- ---------- ----------
 Weighted average diluted
  common shares outstanding     406.6     406.1      406.2      405.3
                             --------- --------- ---------- ----------
Dividends declared per common
 share                        $0.0575   $0.0575    $0.1150    $0.1150
                             --------- --------- ---------- ----------

(1) Diluted earnings per common share is computed by dividing (i)
net earnings, after accounting for the difference between the
dividends on the ESOP preference stock and common stock and after
making adjustments for the incentive compensation plans by (ii) Basic
shares plus the additional shares that would be issued assuming that
all dilutive stock options are exercised and the ESOP preference stock
is converted into common stock. The dilutive earnings adjustment was
$1.6 million and $1.7 million for the thirteen weeks ended June 28,
2003 and June 29, 2002 respectively. The dilutive earnings adjustment
was $3.2 million and $3.4 million for the twenty-six weeks ended June
28, 2003 and June 29, 2002 respectively.




                            CVS CORPORATION
                 Consolidated Condensed Balance Sheets
                              (Unaudited)


                                                     June 28, Dec. 28,
In millions, except share and per share amounts        2003     2002
                                                     -------- --------
Assets:
 Cash and cash equivalents                            $566.8   $700.4
 Accounts receivable, net                            1,088.6  1,019.3
 Inventories                                         3,800.7  4,013.9
 Deferred income taxes                                 208.8    216.4
 Other current assets                                   31.2     32.1
                                                     -------  --------
   Total current assets                              5,696.1  5,982.1

 Property and equipment, net                         2,448.1  2,215.8
 Goodwill                                              889.0    878.9
 Intangible assets, net                                365.0    351.4
 Deferred income taxes                                   6.6      6.6
 Other assets                                          215.9    210.5
                                                     -------  --------
   Total assets                                     $9,620.7 $9,645.3
                                                     -------  --------

Liabilities:
 Accounts payable                                   $1,463.6 $1,707.9
 Accrued expenses                                    1,226.9  1,361.2
 Short-term borrowings                                     -      4.8
 Current portion of long-term debt                     332.1     32.0
                                                     -------  --------
   Total current liabilities                         3,022.6  3,105.9

 Long-term debt                                        775.9  1,076.3
 Other long-term liabilities                           258.2    266.1

Shareholders' equity:
 Preference stock, series one ESOP convertible, par
  value $1.00:
  authorized 50,000,000 shares; issued and
  outstanding 4,587,000 shares at June 28, 2003
  and 4,685,000 shares at December 28, 2002            245.2    250.4
 Common stock, par value $0.01: authorized
  1,000,000,000 shares;
  issued 409,591,000 shares at June 28, 2003 and
  409,286,000 shares at December 28, 2002                4.1      4.1
 Treasury stock, at cost: 15,440,000 shares at June
  28, 2003 and 16,215,000 shares at December 28, 2002 (447.1)  (469.5)
 Guaranteed ESOP obligation                           (194.4)  (194.4)
 Capital surplus                                     1,545.6  1,546.6
 Accumulated other comprehensive loss                  (44.6)   (44.6)
 Retained earnings                                   4,455.2  4,104.4
                                                     -------  --------
   Total shareholders' equity                        5,564.0  5,197.0
                                                     -------  --------
Total liabilities and shareholders' equity          $9,620.7 $9,645.3
                                                     -------  --------




                            CVS CORPORATION
            Consolidated Condensed Statements of Cash Flows
                              (Unaudited)
                                                        26 Weeks Ended
                                                         June    June
In millions                                               28,     29,
                                                         2003    2002
                                                       ------ -------
Cash flows from operating activities:
 Net earnings                                          $396.1  $352.1
 Adjustments required to reconcile net earnings to net
  cash provided by operating activities:
    Depreciation and amortization                       168.0   153.8
    Deferred income taxes and other noncash items         9.9    49.8
 Change in operating assets and liabilities,
  providing/(requiring) cash, net of effects from
  acquisitions:
    Accounts receivable, net                            (50.1)  (37.9)
    Inventories                                         217.8    42.6
    Other current assets                                  8.1     4.3
    Other assets                                         (1.9)   (8.7)
    Accounts payable                                   (244.2) (200.6)
    Accrued expenses                                   (154.3)   (4.1)
    Other long-term liabilities                          (4.4)   (3.0)
                                                       ------- -------
Net cash provided by operating activities               345.0   348.3
                                                       ------- -------

Cash flows from investing activities:
 Additions to property and equipment                   (406.7) (590.3)
 Proceeds from sale-leaseback transactions               28.1   135.5
 Acquisitions (net of cash)                             (68.0)  (32.5)
 Proceeds from sale or disposal of assets                 3.8    13.4
                                                       ------- -------
Net cash used in investing activities                  (442.8) (473.9)
                                                       ------- -------

Cash flow from financing activities:
 (Reductions in) additions to short-term borrowings      (4.8)  252.6
 Dividends paid                                         (45.3)  (45.0)
 Reductions in long-term debt                            (0.3)   (2.7)
 Proceeds from exercise of stock options                 14.6    17.7
                                                       ------- -------
Net cash (used in) provided by financing activities     (35.8)  222.6
                                                       ------- -------

Net (decrease) increase in cash and cash equivalents   (133.6)   97.0
Cash and cash equivalents at beginning of period        700.4   236.3
                                                       ------- -------
Cash and cash equivalents at end of period             $566.8  $333.3
                                                       ------- -------
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 30, 2003
Words:1610
Previous Article:The St. Paul Companies Reports Results.
Next Article:ENDESA First Half 2003 Consolidated Results; Net Income Was Euro 876 Million, a 4.7% Increase over the Same Period Of 2002.
Topics:



Related Articles
CVS Corporation Reports Record Fourth Quarter and Year Results.
CVS Corporation March Sales Increase 12.6%; Company Raises First Quarter Earnings Guidance.
CVS Corporation Reports Fourth Quarter and Year-End Results.
CVS Holds Annual Investor Conference; Announces Plans to Enter Minneapolis, MN.
Zacks Buy List Highlights: Arrow Electronics, RadioShack, CVS Corporation, and EMC Corporation.
Zacks Brokerage Buy List: Abbott, Anheuser-Busch, CVS Corporation and General Electric.
CVS Corporation Q4 2005 Earnings Conference Call - Research and Markets Offers a Transcript of 'CVS Corporation' Conference Call.
Zacks Bull and Bear of the Day Highlights: United Natural Foods, CONMED Corporation, Owens-Illinois and CVS Corporation.
CVS Corporation Reports Record Second Quarter Diluted EPS Of $0.40 Quarterly Net Earnings Rise 22.5%, Leading to Record First Half Results.
CVS Reports Record Sales and Earnings in Fourth Quarter and Year 2006.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles